Frontier Capital Management CO LLC Amneal Pharmaceuticals, Inc. Transaction History

Frontier Capital Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $1.3 Million - $4.03 Million	-567,066 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $1.51 Million - $3.34 Million	-233,715 Reduced 29.19%	567,066 $4.07 Million
Q1 2019 May 07, 2019	SELL	$11.87 - $14.84 $19.6 Million - $24.5 Million	-1,649,433 Reduced 67.32%	800,781 $11.3 Million
Q4 2018 Jan 25, 2019	SELL	$13.09 - $21.49 $5.58 Million - $9.16 Million	-426,153 Reduced 14.82%	2,450,214 $33.2 Million
Q3 2018 Oct 30, 2018	BUY	$16.4 - $24.27 $12.8 Million - $18.9 Million	777,764 Added 37.06%	2,876,367 $63.8 Million

Q2 2018 Aug 03, 2018	BUY	$13.95 - $20.2 $29.3 Million - $42.4 Million	2,098,603 New	2,098,603 $34.4 Million

178

107M

330K

81.9K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $961M
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.